Evidence map›Paper›PMID 20056916›Full record

ArticleCirculation research2010

Reduced sox9 function promotes heart valve calcification phenotypes in vivo.

Jacqueline D Peacock, Agata K Levay, Devin B Gillaspie, Ge Tao, Joy Lincoln

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Bellidifolin Inhibits SRY-Related High Mobility Group-Box Gene 9 to Block TGF-Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  17. Spontaneous Degenerative Aortic Valve Disease in New Zealand Obese Mice.Journal of the American Heart Association · 2021
    Article
  18. Article
  19. Roles of Nuclear Receptors in Vascular Calcification.International journal of molecular sciences · 2021
    Review
  20. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients.International journal of molecular sciences · 2021
    Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jacqueline D PeacockDepartment of Molecular and Cellular Pharmacology, Leonard M. Miller School of Medicine, University of Miami, 1600 NW 10th Ave., Miami, FL 33136, USA.
Agata K Levay
Devin B Gillaspie
Ge Tao
Joy Lincoln
Cellular Research (United States) · USInstitute of Molecular and Cell Biology · RU

Funding

TRAINING PROGRAMS IN CARDIOVASCULAR PHARMACOLOGYT32HL007188 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SZCZESNA-CORDARY, DANUTA · 1985 to 2011
$3.8M
Molecular regulation of heart valve development and function.R01HL091878 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LINCOLN, JOY · 2008 to 2012
$2.2M
NHLBI NIH HHS 5T32HL007188-28NHLBI NIH HHS R01 HL091878NHLBI NIH HHS T32 HL007188
6 · The paper itself

Abstract

rationaleCalcification of heart valve structures is the most common form of valvular disease and is characterized by the appearance of bone-like phenotypes within affected structures. Despite the clinical significance, the underlying etiology of disease onset and progression is largely unknown and valve replacement remains the most effective treatment. The SRY-related transcription factor Sox9 is expressed in developing and mature heart valves, and its function is required for expression of cartilage-associated proteins, similar to its role in chondrogenesis. In addition to cartilage-associated defects, mice with reduced sox9 function develop skeletal bone prematurely; however, the ability of sox9 deficiency to promote ectopic osteogenic phenotypes in heart valves has not been examined.

objectiveThis study aims to determine the role of Sox9 in maintaining connective tissue homeostasis in mature heart valves using in vivo and in vitro approaches. METHODS AND

resultsUsing histological and molecular analyses, we report that, from 3 months of age, Sox9(fl/+);Col2a1-cre mice develop calcific lesions in heart valve leaflets associated with increased expression of bone-related genes and activation of inflammation and matrix remodeling processes. Consistently, ectopic calcification is also observed following direct knockdown of Sox9 in heart valves in vitro. Furthermore, we show that retinoic acid treatment in mature heart valves is sufficient to promote calcific processes in vitro, which can be attenuated by Sox9 overexpression.

conclusionsThis study provides insight into the molecular mechanisms of heart valve calcification and identifies reduced Sox9 function as a potential genetic basis for calcific valvular disease.

Indexed as

Age FactorsAgingAnimalsAnimals, NewbornCalcinosisCalciumChick EmbryoCollagen Type IIDisease Models, AnimalDown-RegulationExtracellular MatrixFemaleGene Knockdown TechniquesGenotypeHeart Valve DiseasesInflammationCalciumCol2a1 protein, mouseCollagen Type IICre recombinaseIntegrasesSox9 protein, mouseSOX9 Transcription FactorTretinoin

Identifiers

PMID20056916
PMCPMC2863131
OpenAlexW2131672223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.